Experience. Commitment. Results.
Progenics Pharmaceuticals, Inc. (PGNX) related to its sale to Lantheus Holdings, Inc. Under the terms of the transaction, each share of Progenics common stock issued will automatically be converted into the right to receive 0.2502 of a share of Lantheus common stock for each share of Progenics common stock.
Roan Resources, Inc (ROAN) related to its sale to Citizen Energy Operating, LLC. Under the terms of the transaction, each share of Roan common stock will be converted into the right to receive $1.52 in cash for each share of Roan common stock owned.
Charden Heathcare Acquisition Corp. (CHAC) related to its combination with BiomX Ltd. Pursuant to the terms of the Merger Agreement, BiomX’s securityholders will receive an aggregate of 16,625,000 Chardan shares. As a result of the Proposed Transaction, Chardan’s public stockholders will only own approximately 20% of Chardan’s stock.
Empire Resort, Inc (NYNY) related to its sale to Kien Huat Realty III Limited and Genting Malaysia Berhad. Under the terms of the transaction, each share of NYNY common stock will be converted into the right to receive $9.74 in cash for each share of NYNY common stock owned.
Arotech Corporation (ARTX) related to its sale to Argonaut Intermediate, Inc. Under the terms of the transaction, each share of ARTX common stock will be converted into the right to receive $3.00 in cash for each share of ARTX common stock owned.
Alder Biopharmaceuticals, Inc. (ALDR) related to its sale to Lundbeck LLC. Under the terms of the proposed agreement, each share of ALDR common stock will be converted into the right to receive $18.00 in cash for each share of ALDR common stock owned.
SemGroup Corp. (SEMG) related to its sale to Energy Transfer LP. Under the terms of the transaction, each share of SEMG common stock will be converted into the right to receive $6.80 in cash for each share of SEMG common stock owned.
Highlands Bankshares, Inc. (HLND) related to its sale to First Community Bankshares, Inc. Under the terms of the transaction, each share of HLND common stock will be converted into the right to $8.80 in cash for each share of HLND common stock owned.
Fibrocell Science, Inc. (FCSC) related to its sale to Castle Creek Pharmeceutical Holdings, Inc. Under the terms of transaction, each share of FCSC common stock will be converted into right to receive $3.00 in cash for each share of FCSC common stock owned.
United Community Financial Corp. (UCFC) related to its sale to First Defiance Financial Corp. Under the terms of the transaction, each share of UCFC common stock will be converted into the right to receive $0.01 in cash for each share of UCFC common stock owned.